Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

265 Odcinki

  1. SSRIs and Anticoagulants: Navigating Bleeding Risk

    Opublikowany: 12.03.2025
  2. Lamotrigine and the Heart: What You Need to Know

    Opublikowany: 7.03.2025
  3. After the Last Dose: Understanding Antipsychotic Discontinuation

    Opublikowany: 2.03.2025
  4. Understanding Lamotrigine's Cardiac Effects

    Opublikowany: 25.02.2025
  5. Rethinking Falls: Are Sleep Medications Really to Blame?

    Opublikowany: 20.02.2025
  6. Navigating Lamotrigine's Side Effects

    Opublikowany: 15.02.2025
  7. Iloperidone in Bipolar Disorder: A New Treatment Option?

    Opublikowany: 10.02.2025
  8. Lamotrigine: Pearls for Prescribing

    Opublikowany: 5.02.2025
  9. Beyond Benzos: New Frontiers in Agitation Management

    Opublikowany: 31.01.2025
  10. KarXT: A New Dawn in Antipsychotic Treatment

    Opublikowany: 26.01.2025
  11. Rethinking Agitation Management: From Force to Partnership

    Opublikowany: 21.01.2025
  12. COVID Brain Fog: Repurposing Famotidine

    Opublikowany: 16.01.2025
  13. Beyond Restraints: De-Escalation in Behavioral Emergencies

    Opublikowany: 11.01.2025
  14. Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial

    Opublikowany: 6.01.2025
  15. Unraveling Agitation: Mania vs. Substance Use

    Opublikowany: 1.01.2025
  16. Pushing the Boundaries: Exploring High-Dose Antipsychotics

    Opublikowany: 27.12.2024
  17. The Psychodynamic Prescriber

    Opublikowany: 22.12.2024
  18. From Inpatient to Outpatient: Initiating Benzodiazepine Tapering

    Opublikowany: 17.12.2024
  19. The Power of Alliance in Psychopharmacology

    Opublikowany: 12.12.2024
  20. Antipsychotics in Youth: Balancing Metabolic Risk

    Opublikowany: 7.12.2024

1 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site